Study of OCA in Combination With BZF Evaluating Efficacy, Safety and Tolerability in Participants With PBC

Clinical trial NCT05239468 · COMPLETED

Trial details

NCT number: NCT05239468
Sponsor: Intercept Pharmaceuticals
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Primary Biliary Cholangitis

Start date: 2022-03-21
Primary completion: 2025-09-01
Enrollment: 72

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.